Top Purchase Related
Home
>
Node
>
Subnode

The tat gene and protein of the human immunodeficiency virus type 1

Caputo, A.; Grossi, M.P.; Rossi, C.; Campioni, D.; Balboni, P.G.; Corallini, A.; Barbanti-Brodano, G.

New Microbiologica 18(1): 87-110

1995

ISSN/ISBN: 1121-7138
PMID: 7760763
Document Number: 440882

Document emailed within 1 workday
Secure & encrypted payments

Bond, V.C.; Huang, M.B.; Person, B.; Hairston, R.; Ye, X.Y.; Saltarelli, M. 1997: Effects of the human immunodeficiency virus type 1 Rev protein on reporter gene and host T-cell gene expression Cellular and Molecular Biology 43(7): 995-1005
Machado, A.A.; Hirsch, I.; Figueiredo, J.F.; Martinez, R.; de Freitas-Silva, G.; Chermann, J.C.; Covas, D.T. 1996: Occurrence of false positives in tests with synthetic peptides for the analysis of antibodies against the human immunodeficiency virus type 2 (HIV-2) in Brazilian patients infected with the human immunodeficiency virus type 1 (HIV-1) Revista da Sociedade Brasileira de Medicina Tropical 29(6): 615-617
Balzarini, J.; Velazquez, S.; San-Felix, A.; Karlsson, A.; Perez-Perez, M.J.; Camarasa, M.J.; De Clercq, E. 1993: Human immunodeficiency virus type 1-specific [2',5'-bis-O-(tert- butyldimethylsilyl)-beta-D-ribofuranosyl]-3'-spiro-5"-(4"-amino-1",2"- oxathiole-2",2"-dioxide)-purine analogues show a resistance spectrum that is different from that of the human immunodeficiency virus type 1-specific non-nucleoside analogues Molecular Pharmacology 43(1): 109-114
Yusim, K.; Peeters, M.; Pybus, O.G.; Bhattacharya, T.; Delaporte, E.; Mulanga, C.; Muldoon, M.; Theiler, J.; Korber, B. 2001: Using human immunodeficiency virus type 1 sequences to infer historical features of the acquired immune deficiency syndrome epidemic and human immunodeficiency virus evolution Philosophical Transactions of the Royal Society of London. Series B Biological Sciences 356(1410): 855-866
Reddy, M.V.; Desai, M.; Jeyapaul, J.; Prasad, D.D.; Seshamma, T.; Palmeri, D.; Khan, S.A. 1992: Functional analysis of the N-terminal domain of Tat protein of the human immunodeficiency virus type 1 Oncogene 7(9): 1743-1748
Hathout, Y.; Fabris, D.; Han, M.S.; Sowder, R.C.; Henderson, L.E.; Fenselau, C. 1996: Characterization of intermediates in the oxidation of zinc fingers in human immunodeficiency virus type 1 nucleocapsid protein P7 Drug Metabolism and Disposition: the Biological Fate of Chemicals 24(12): 1395-1400
Kline, M.W.; Lewis, D.E.; Hollinger, F.B.; Reuben, J.M.; Hanson, L.C.; Kozinetz, C.A.; Dimitrov, D.H.; Rosenblatt, H.M.; Shearer, W.T. 1994: A comparative study of human immunodeficiency virus culture, polymerase chain reaction and anti-human immunodeficiency virus immunoglobulin A antibody detection in the diagnosis during early infancy of vertically acquired human immunodeficiency virus infection Pediatric Infectious Disease Journal 13(2): 90-94
Koyanagi, A.; Humphrey, J.H.; Ntozini, R.; Nathoo, K.; Moulton, L.H.; Iliff, P.; Mutasa, K.; Ruff, A.; Ward, B.; Chidawanyika, H.; Hargrove, J.; Mahomva, A.I.; Majo, F.; Malaba, L.C.; Mbizvo, M.T.; Mzengeza, F.; Ndhlovu, M.; Piwoz, E.; Propper, L.; Rambanepasi, P.; Ruff, A.J.; Tavengwa, N.; Zijenah, L.S.; Zunguza, C.D.; Zvandasara, P. 2011: Morbidity among human immunodeficiency virus-exposed but uninfected, human immunodeficiency virus-infected, and human immunodeficiency virus-unexposed infants in Zimbabwe before availability of highly active antiretroviral therapy Pediatric Infectious Disease Journal 30(1): 45-51
Frankel, F.R.; Hegde, S.; Lieberman, J.; Paterson, Y. 1995: Induction of cell-mediated immune responses to human immunodeficiency virus type 1 Gag protein by using Listeria monocytogenes as a live vaccine vector Journal of Immunology 155(10): 4775-4782
Nagot, N.; Ouedraogo, A.; Konate, I.; Weiss, H.A.; Foulongne, V.; Defer, M.C.; Sanon, A.; Becquart, P.; Segondy, M.; Sawadogo, A.; Van de Perre, P.; Mayaud, P.; Bahembera, E.; Berthe, A.; Coulibaly, M.; Defer, M.-C.; Diallo, R.; Djagbare, D.; Konate, I.; Ky-Dama, F.; M'Boutiki, G.T.; Meda, N.; Millogo, I.; Ouedraogo, A.; Ouedraogo, D.; Rouet, F.ço.; Sanon, A.; Sawadogo, H.; Vallo, R.; Andonaba, J.-B.; Sawadogo, A.; Mayaud, P.; Weiss, H.A.; Nagot, N.; Becquart, P.; Foulongne, V.; Segondy, M.; Van de Perre, P. 2008: Roles of clinical and subclinical reactivated herpes simplex virus type 2 infection and human immunodeficiency virus type 1 (HIV-1)-induced immunosuppression on genital and plasma HIV-1 levels Journal of Infectious Diseases 198(2): 241-249
Okuku, H.Selassie.; Sanders, E.J.; Nyiro, J.; Ngetsa, C.; Ohuma, E.; McClelland, R.Scott.; Price, M.A.; Graham, S.M. 2011: Factors associated with herpes simplex virus type 2 incidence in a cohort of human immunodeficiency virus type 1-seronegative Kenyan men and women reporting high-risk sexual behavior Sexually Transmitted Diseases 38(9): 837-844
Rosenthal, A.; Ulrich, R.; Billwitz, H.; Frank, R.; Blöcker, H. 1987: Chemical-enzymatic synthesis, cloning and expression of a synthetic gene coding for an env protein fragment of the human T-cell leukemia virus type 1 Nucleic Acids Symposium Series 18: 233-236
Yang, J.; Yi, Y.; Wang, J. 2000: Cell cycle G2 arrest, cell death and nuclear localization induced by human immunodeficiency virus type 1 protein R (VPR) in cervical cancer cells Zhonghua Shi Yan he Lin Chuang Bing du Xue Za Zhi 14(3): 223-226; 301
Fujii, T. 2005: Diagnostic tests: Human immunodeficiency virus type 1, type 2 (HIV-1, HIV 2) Nihon Rinsho. Japanese Journal of Clinical Medicine 63(Suppl 7): 434-437
Mmbaga, E.J.; Leyna, G.H.; Stray-Pedersen, B.; Klepp, K.-I. 2011: Herpes simplex virus type-2 and human immunodeficiency virus infections in a rural population in Kilimanjaro Tanzania East African Journal of Public Health 8(1): 28-32
Devare, S.G.; Desai, S.M.; Rupprecht, K.R.; Allen, R.G.; Dawson, G.J.; Hunt, J.C.; Casey, J.M. 1988: Genes of human immunodeficiency virus, type i (HIV-I), their expression in Escherichia coli, and their utility in diagnosis of virus infection Indian Journal of Biochemistry and Biophysics 25(6): 504-509
Mahiane, S.G.; Ndong Nguema, E.P.; Pretorius, C.; Auvert, B. 2010: Mathematical models for coinfection by two sexually transmitted agents: the human immunodeficiency virus and herpes simplex virus type 2 case Applied Statistics 59(4): 547-572
Scott-Wright, A.; Hakre, S.; Bryan, J.P.; Jaramillo, R.; Reyes, L.G.; Cruess, D.; Macarthy, P.O.; Gaydos, J.C. 1997: Hepatitis B virus, human immunodeficiency virus type-1, and syphilis among women attending prenatal clinics in Belize, Central America American Journal of Tropical Medicine and Hygiene 56(3): 285-290
Dada, A.J.; Ajayi, A.O.; Diamondstone, L.; Quinn, T.C.; Blattner, W.A.; Biggar, R.J. 1998: A serosurvey of Haemophilus ducreyi, syphilis, and herpes simplex virus type 2 and their association with human immunodeficiency virus among female sex workers in Lagos, Nigeria Sexually Transmitted Diseases 25(5): 237-242
Sabidó, M.; Lahuerta, M.; Montoliu, A.; Gonzalez, V.; Hernández, G.; Giardina, F.; Monzón, J.é E.; Pedroza, M.I.; Casabona, J. 2011: Human immunodeficiency virus, sexually transmitted infections, and risk behaviors among clients of sex workers in Guatemala: are they a bridge in human immunodeficiency virus transmission? Sexually Transmitted Diseases 38(8): 735-742